These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

222 related items for PubMed ID: 17940749

  • 1. Asenapine, a novel psychopharmacologic agent: preclinical evidence for clinical effects in schizophrenia.
    Frånberg O, Wiker C, Marcus MM, Konradsson A, Jardemark K, Schilström B, Shahid M, Wong EH, Svensson TH.
    Psychopharmacology (Berl); 2008 Feb; 196(3):417-29. PubMed ID: 17940749
    [Abstract] [Full Text] [Related]

  • 2. Effects of asenapine on prefrontal N-methyl-D-aspartate receptor-mediated transmission: involvement of dopamine D1 receptors.
    Jardemark K, Marcus MM, Shahid M, Svensson TH.
    Synapse; 2010 Nov; 64(11):870-4. PubMed ID: 20842721
    [Abstract] [Full Text] [Related]

  • 3. Asenapine elevates cortical dopamine, noradrenaline and serotonin release. Evidence for activation of cortical and subcortical dopamine systems by different mechanisms.
    Frånberg O, Marcus MM, Ivanov V, Schilström B, Shahid M, Svensson TH.
    Psychopharmacology (Berl); 2009 Jun; 204(2):251-64. PubMed ID: 19198810
    [Abstract] [Full Text] [Related]

  • 4. Asenapine increases dopamine, norepinephrine, and acetylcholine efflux in the rat medial prefrontal cortex and hippocampus.
    Huang M, Li Z, Dai J, Shahid M, Wong EH, Meltzer HY.
    Neuropsychopharmacology; 2008 Nov; 33(12):2934-45. PubMed ID: 18418367
    [Abstract] [Full Text] [Related]

  • 5. Adjunctive treatment with asenapine augments the escitalopram-induced effects on monoaminergic outflow and glutamatergic neurotransmission in the medial prefrontal cortex of the rat.
    Björkholm C, Frånberg O, Malmerfelt A, Marcus MM, Konradsson-Geuken Å, Schilström B, Jardemark K, Svensson TH.
    Int J Neuropsychopharmacol; 2014 Oct 31; 18(3):. PubMed ID: 25522408
    [Abstract] [Full Text] [Related]

  • 6. Reboxetine enhances the olanzapine-induced antipsychotic-like effect, cortical dopamine outflow and NMDA receptor-mediated transmission.
    Marcus MM, Jardemark K, Malmerfelt A, Björkholm C, Svensson TH.
    Neuropsychopharmacology; 2010 Aug 31; 35(9):1952-61. PubMed ID: 20463659
    [Abstract] [Full Text] [Related]

  • 7. Enhanced efficacy of both typical and atypical antipsychotic drugs by adjunctive alpha2 adrenoceptor blockade: experimental evidence.
    Wadenberg ML, Wiker C, Svensson TH.
    Int J Neuropsychopharmacol; 2007 Apr 31; 10(2):191-202. PubMed ID: 16707032
    [Abstract] [Full Text] [Related]

  • 8. Involvement of 5-HT2A receptor and α2-adrenoceptor blockade in the asenapine-induced elevation of prefrontal cortical monoamine outflow.
    Frånberg O, Marcus MM, Svensson TH.
    Synapse; 2012 Jul 31; 66(7):650-60. PubMed ID: 22362425
    [Abstract] [Full Text] [Related]

  • 9. Adjunctive alpha2-adrenoceptor blockade enhances the antipsychotic-like effect of risperidone and facilitates cortical dopaminergic and glutamatergic, NMDA receptor-mediated transmission.
    Marcus MM, Wiker C, Frånberg O, Konradsson-Geuken A, Langlois X, Jardemark K, Svensson TH.
    Int J Neuropsychopharmacol; 2010 Aug 31; 13(7):891-903. PubMed ID: 19835668
    [Abstract] [Full Text] [Related]

  • 10. Augmentation by escitalopram, but not citalopram or R-citalopram, of the effects of low-dose risperidone: behavioral, biochemical, and electrophysiological evidence.
    Marcus MM, Jardemark K, Malmerfelt A, Gertow J, Konradsson-Geuken A, Svensson TH.
    Synapse; 2012 Apr 31; 66(4):277-90. PubMed ID: 22121030
    [Abstract] [Full Text] [Related]

  • 11. Topiramate augments the antipsychotic-like effect and cortical dopamine output of raclopride.
    Eltayb A, Wadenberg ML, Schilström B, Svensson TH.
    Naunyn Schmiedebergs Arch Pharmacol; 2005 Nov 31; 372(3):195-202. PubMed ID: 16284783
    [Abstract] [Full Text] [Related]

  • 12. Differential regional and dose-related effects of asenapine on dopamine receptor subtypes.
    Tarazi FI, Moran-Gates T, Wong EH, Henry B, Shahid M.
    Psychopharmacology (Berl); 2008 May 31; 198(1):103-11. PubMed ID: 18297468
    [Abstract] [Full Text] [Related]

  • 13. Expression of 5-HT2A receptors in prefrontal cortex pyramidal neurons projecting to nucleus accumbens. Potential relevance for atypical antipsychotic action.
    Mocci G, Jiménez-Sánchez L, Adell A, Cortés R, Artigas F.
    Neuropharmacology; 2014 Apr 31; 79():49-58. PubMed ID: 24211653
    [Abstract] [Full Text] [Related]

  • 14. Asenapine exerts distinctive regional effects on ionotropic glutamate receptor subtypes in rat brain.
    Tarazi FI, Choi YK, Gardner M, Wong EH, Henry B, Shahid M.
    Synapse; 2009 May 31; 63(5):413-20. PubMed ID: 19177511
    [Abstract] [Full Text] [Related]

  • 15. Selective enhancement of mesocortical dopaminergic transmission by noradrenergic drugs: therapeutic opportunities in schizophrenia.
    Masana M, Bortolozzi A, Artigas F.
    Int J Neuropsychopharmacol; 2011 Feb 31; 14(1):53-68. PubMed ID: 20701825
    [Abstract] [Full Text] [Related]

  • 16. ACP-103, a 5-HT2A/2C inverse agonist, potentiates haloperidol-induced dopamine release in rat medial prefrontal cortex and nucleus accumbens.
    Li Z, Ichikawa J, Huang M, Prus AJ, Dai J, Meltzer HY.
    Psychopharmacology (Berl); 2005 Dec 31; 183(2):144-53. PubMed ID: 16220333
    [Abstract] [Full Text] [Related]

  • 17. A systematic microdialysis study of dopamine transmission in the accumbens shell/core and prefrontal cortex after acute antipsychotics.
    Tanda G, Valentini V, De Luca MA, Perra V, Serra GP, Di Chiara G.
    Psychopharmacology (Berl); 2015 Apr 31; 232(8):1427-40. PubMed ID: 25345736
    [Abstract] [Full Text] [Related]

  • 18. Asenapine for schizophrenia and bipolar disorder: a review of the efficacy and safety profile for this newly approved sublingually absorbed second-generation antipsychotic.
    Citrome L.
    Int J Clin Pract; 2009 Dec 31; 63(12):1762-84. PubMed ID: 19840150
    [Abstract] [Full Text] [Related]

  • 19. Enhanced cortical dopamine output and antipsychotic-like effects of raclopride by alpha2 adrenoceptor blockade.
    Hertel P, Fagerquist MV, Svensson TH.
    Science; 1999 Oct 01; 286(5437):105-7. PubMed ID: 10506554
    [Abstract] [Full Text] [Related]

  • 20. Enhanced cortical dopamine output and antipsychotic-like effect of raclopride with adjunctive low-dose L-dopa.
    Eltayb A, Wadenberg ML, Svensson TH.
    Biol Psychiatry; 2005 Aug 15; 58(4):337-43. PubMed ID: 16102547
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.